Back to medications
Medication monograph

emicizumab

Monoclonal AntibodiesBispecific AntibodiesHematologic AgentsHemophilia A TreatmentHemostatics

Clinical reference

Product monograph

HEMLIBRA- emicizumab injection, solution

Brands & formulations

Family members

HEMLIBRA

Marketed
30 MGSUBCUTANEOUSSOLUTION[ "emicizumab" ]
Product monograph

HEMLIBRA

Marketed
60 MGSUBCUTANEOUSSOLUTION[ "emicizumab" ]
Product monograph

HEMLIBRA

Marketed
105 MGSUBCUTANEOUSSOLUTION[ "emicizumab" ]
Product monograph

HEMLIBRA

Marketed
150 MGSUBCUTANEOUSSOLUTION[ "emicizumab" ]
Product monograph

Classification

Chemical class
Monoclonal Antibodies, Bispecific Antibodies
Clinical class
Hematologic Agents, Hemophilia A Treatment
Banks class
Hemostatics